RSV Vaccination Programme for Older Adults: A Scotland-Wide Study on RSVpreF Vaccine Safety
Study results indicated a good safety profile of the RSV vaccine for older eligible adults aged 75 to 79 years, although a small increased risk of GBS was identified in both analyses. Excess risk levels of GBS from vaccination align with other studies.
Authors
- Sam Ghebrehewet (ORCID: https://orcid.org/0000-0001-5012-5280)
- Ting Shi (ORCID: https://orcid.org/0000-0002-4101-4535)
- Chris Robertson (ORCID: https://orcid.org/0000-0001-6848-5241)
- Lucy Cullen (ORCID: https://orcid.org/0000-0001-6539-6710)
- Christopher Sullivan (ORCID: https://orcid.org/0009-0004-9181-3679)
- Taimoor Hasan (ORCID: https://orcid.org/0000-0003-3607-3490)
- Kimberly Marsh (ORCID: https://orcid.org/0000-0002-2721-1639)
- J. Claire Cameron (ORCID: https://orcid.org/0000-0001-5263-3086)
- Cheryl Gibbons
Institutions
- University of Strathclyde (GB)
- Public Health Scotland (GB)
- University of Edinburgh (GB)
Publication Details
- Journal
- Vaccines
- Published
- 2025-10-24
- DOI
- https://doi.org/10.3390/vaccines13111088
- Citations
- 1
- Primary Topic
- Viral Infections and Immunology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.39